4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-25-022861
Chief Executive Officer sold 16,800 shares at $40.00 ($672,020)
- Chief Executive Officer acquired 16,800 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Robinson Chandler · Chief Executive Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-07-14 | Option exercise : show line 1 in the form | +16,800 | $0.01 | $84 | 90,272 | D |
| 2025-07-14 | Sale : show line 2 in the form | −16,800 | $40.00 | $672,020 | 73,472 | D |
| Open-market sales · 16,800 sh · avg $40.00 · $672,020 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-14 | Option exercise : show line 3 in the form Stock Options | −16,800 | 0 | D |
Loading xslF345X05/rdgdoc.xml…